Evidence map›Paper›PMID 21324552›Full record

ReviewMedicina intensiva2011

[Role of viral infections in immunosuppressed patients].

M Salavert, R Granada, A Díaz, R Zaragoza

Open access · greenAbstract readEnglish AbstractReview
In one paragraph

Review in Medicina intensiva, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

M SalavertUnidad de Enfermedades Infecciosas, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
R Granada
A Díaz
R Zaragoza
Hospital Universitari i Politècnic La Fe · ESBellvitge University Hospital · ESHospital Universitario Virgen del Rocío · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Being a solid organ and hematopoietic stem cell transplant recipient as well as receiving chemotherapy for a malignant hematological disease clearly predispose the subject to a variety of viral infections, both common and opportunistic diseases. The patient may have acquired these infections from the community as well as from the donor organ (donor-derived infections) and/or from reactivation of an endogenous latent virus. Herpes viruses and especially the cytomegalovirus and Epstein-Barr virus are among the most common of the opportunistic viral pathogens affecting these patients, in addition to respiratory viruses. Treatment consists in antiviral drug therapies combined with the reduction in the degree of the induced immunosuppression. A review of the literature has been performed in order to update the epidemiology, pathogenesis, clinical manifestations and therapeutic approach of the viral infections in these immunocompromised patients.

Indexed as

Critical CareCritical IllnessImmunocompromised HostAntibodies, Monoclonal, Murine-DerivedAntiviral AgentsComorbidityCross InfectionDisease SusceptibilityHerpesviridae InfectionsHumansImmunosuppressive AgentsLymphoproliferative DisordersOpportunistic InfectionsPostoperative ComplicationsRisk FactorsRituximabAntibodies, Monoclonal, Murine-DerivedAntiviral AgentsImmunosuppressive AgentsRituximab

Identifiers

PMID21324552
PMCPMC7115649
OpenAlexW2001651164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.